Abzu

Abzu is a technology that enhances the design of RNA therapeutics using artificial intelligence. It enables researchers to create more effective drug compounds by relying on data-driven insights.

This approach minimizes the time and resources spent on less promising candidates, leading to faster development cycles. By combining existing research with predictive modeling, Abzu streamlines the journey from drug design to validation. This results in more reliable outcomes and increases the chances of success for new medications.

With its focus on improving drug safety and efficiency, Abzu supports researchers in identifying viable drug candidates and refining therapeutic strategies.